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Summary. Pro-opiomelanocortin (POMC) mRNA was 
detected on paraffin sections by in situ hybridization 
(ISH) in corticotrophs of 12 nontumorous pituitaries, 
11 functioning corticotroph, and 11 silent pituitary ad- 
enomas. ISH combined with immunocytochemistry for 
adrenocorticotrophic hormone (ACTH), a POMC-de- 
rived peptide, was also performed. ACTH immunoreac- 
tive cells of the anterior lobes and those invading the 
posterior lobe showed a high or moderate level of 
POMC mRNA that was not correlated with the intensity 
of ACTH immunoreactivity. Variable levels of POMC 
gene expression were present in Crooke's cells, cortico- 
trophs suppressed by glucocorticoid excess. Most func- 
tioning corticotroph adenomas and silent subtype 1 ad- 
enomas had an intense hybridization signal and ACTH 
immunoreactivity. In silent subtype 2 and 3 adenomas, 
POMC mRNA had a diffuse low level or was absent; 
in these adenomas ACTH immunoreactivity was diffuse, 
restricted to some cells, or negative. The results indicate 
that POMC gene is expressed in both normal and sup- 
pressed nontumorous corticotrophs. Intense signals for 
POMC mRNA are found in most functioning cortico- 
troph adenomas. The difference between POMC gene 
expression in silent 1 and silent 2 and 3 adenomas sug- 
gests that different mechanisms are responsible for the 
lack of endocrine activity. 
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Introduction 
The pituitary corticotroph is the major site of pro-opio- 
melanocortin (POMC) gene expression in man. In this 
cell type, the POMC molecule is processed post-transla- 
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tionally mainly to adrenocorticotrophic hormone 
(ACTH), fl-lipotropin and fl-endorphin, which are readi- 
ly identified by immunocytochemistry. Corticotrophs 
suppressed by glucocorticoid excess are called Crooke's 
cells and are characterized by massive accumulation of 
keratin immunoreactive intermediate filaments. 
Most of the tumors arising in corticotrophs are asso- 
ciated with Cushing's disease or Nelson's syndrome due 
to increased production of ACTH. Electron microscopy 
shows that functioning corticotroph adenomas consist 
of well-differentiated, densely granulated cells. A few 
cases represent sparsely granulated, less differentiated 
adenomas or adenomas with Crooke's hyalinization 
(Kovacs and Horvath 1986; Horvath and Kovacs 1988). 
Some corticotroph adenomas are not associated with 
endocrine symptoms and, based on their ultrastructural 
features, have been divided into three subtypes: silent 
subtype 1 possesses an ultrastructure similar to that of 
the functioning variant; silent subtype2 has small, 
spherical, tear- and heart-shaped granules of 150- 
450 nm and is devoid of microfilaments; silent subtype 
3 tumors contain abundant RER and SER profiles, very 
prominent, multifocal Golgi apparatus, small secretory 
granules (< 200 nm) and nuclei with spheridia (Kovacs 
et al. 1978; Horvath et al. 1980; Hassoun et al. 1982; 
Horvath et al. 1988). The mechanisms responsible for 
the lack of ACTH excess in patients with such tumors 
are unknown. The investigation of POMC gene expres- 
sion in nontumorous corticotrophs and their adenomas 
can contribute to a better understanding of the molecu- 
lar events involved in hormone production. 
The human POMC gene has been cloned and its 
DNA sequence determined (Chang et al. 1980; Whitfeld 
et al. 1982). In the pituitary, POMC mRNA has been : 
detected by Northern blot and/or in situ hybridization 
(ISH) (Kelsey et al. 1986; Lewis etal. 1986; DeBold 
et al. 1988; Farquharson et al. 1990; Lloyd 1990). The 
usefulness of the ISH method for POMC mRNA dem- 
onstration in both functioning and silent corticotroph 
adenomas, using archival, paraffin-embedded speci- 
mens, has been proven by Lloyd et al. (1990). 
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In the present study, the presence of P O M C  m R N A  
was investigated in nontumorous  cort icotrophs and all 
types of  cort icotroph adenomas and compared with their 
A C T H  immunoreact ivi ty and ultrastructural features. 
Materials and methods 
Tissues. Nontumorous pituitaries were obtained at autopsy 
(5 cases) of patients dying of nonendocrine diseases and at surgery 
of patients with the diagnosis of Cushing's disease (7 cases). Corti- 
cotroph adenomas were removed at surgery from patients with 
Cushing's disease (8 cases) and Nelson's syndrome (3 cases). Silent 
corticotroph adenomas included subtype 1 (4 cases), subtype 2 
(3 cases) and subtype 3 (4 cases). All adenomas were previously 
diagnosed based on clinical, histologic, immunocytochemical and 
electron microscopic data. 
Pieces of tumors were fixed in 10% buffered formalin and em- 
bedded in paraffin. Five-micron-thick sections were mounted on 
3-aminopropylmethoxysilane-coated slides. 
Probes. For POMC mRNA demonstration, an oligonucleotide 
probe (NEP-20/4, Dupont Canada Inc. Mississauga, Ont.) of 30 
nucleotides (5'-d(CTT-GCC-CCA-GCG-GAA-GTG-CTC-CAT- 
GGA-GTA(-3') was used. As positive-control probe, oligodeoxyth- 
ymidylates, p(dT) 19-24 (The Midland Certified Reagent Co., Mid- 
land, Tex, USA) that detects poly-adenylated RNA sequences (Pr- 
ingle et al. 1989) was applied. The probes were labeled by the T-end 
method with (35S)dATPc~ S and terminal deoxynucleotidyl trans- 
ferase using a kit (NEP-100, Dupont Canada Inc. Mississauga, 
Ont.) and purified with NENSORBTU20 cartridge included in the 
kit. 
In situ hybridization. ISH was carried out on paraffin sections ap- 
plying 3 • 105 CPM of POMC probe and I • 106 p(dT) probe as 
described previously (Kovacs et al. J1989; Lloyd et al. 1990). For 
ISH combined with immunocytochemistry, the avidin-biotin-per- 
oxidase complex (ABC) method for ACTH was applied after 2 x 
SSC washings. Anti-hACTH (NIDDKD, Bethesda, Md., diluted 
1:2000, was used. Autoradiography was done with NTB-2 emul- 
sion, diluted 1 : 1 with distilled water containing 0.3 M ammonium 
acetate, as previously described (Kovacs et al. 1989). Slides were 
exposed to emulsion for 1 week at 4 ~ C and then developed. 
The specificity of hybridization was checked by: (1)prediges- 
tion of tissue sections with 100 ng/ml RNase A (Sigma, St. Louis, 
MO, USA); (2) competition study with tenfold excess of unlabeled 
probe; (3) human kidney used as negative control. 
labeling prevailed (Fig. 4). Moderate  densities of  silver 
grains were noted in two adenomas,  which contained 
not only A C T H  but TSH and ~-SU of  glycoprotein hor- 
mones immunoreactivities in a few cells (case 4) or only 
c~-SU in many  cells (case 5). A moderate  signal intensity 
was also present in a sparsely granulated cort icotroph 
adenoma, an adenoma composed of  large Crooke 's  cell 
population, and small cell populat ion with signs of  sup- 
pression and in an atypical cort icotroph adenoma. The 
latter tumor  was composed of  small cells with moderate-  
ly developed rough endoplasmic reticulum (RER) and 
Golgi regions; the small secretory granules (150--300 nm) 
with ovoid, rod, and heart shape were confined to the 
cell periphery; some adenoma cells showed extensive 
hyalinization. In functioning cort icotroph adenomas as- 
sociated with Nelson's syndrome, an intense or weak 
signal was present (Fig. 5). In functioning cort icotroph 
tumors, the level of  POMC gene expression could not 
be correlated with the amount  of  microfilaments in ad- 
enoma cells (Table 1). 
In silent subtype 1 cort icotroph adenomas,  the inten- 
sity of  labeling was similar to that  encountered in func- 
tioning adenomas (Fig. 6). A low level or absence of  
P O M C  gene expression was found in silent subtype 2 
adenomas (Fig. 7 A). The silver granules were evenly dis- 
tributed among adenoma cells despite the focal A C T H  
immunoreactivity. In silent subtype 3 adenomas,  P O M C  
m R N A  presented a low level in one case with diffuse 
immunoreactivi ty for A C T H ;  three cases were negative 
for P O M C  m R N A ;  one adenoma exhibited scattered 
A C T H  immunoreact ive cells; a variable number  of  cells 
immunoreactive for other adenohypophysial  hormones 
was present in all three silent subtype 3 adenomas (Ta- 
ble 2). 
The detection of  poly-adenylated R N A  in adenomas 
indicated the preservation of  m R N A  in formalin-fixed 
paraffin sections (Fig. 7 B). However,  the intensity of  hy- 
bridization signal was not quantified since no informa- 
tion was available on the fixation and processing times 
of  specimens. It  is known that  in paraff in-embedded tis- 
sue, a decrease in the m R N A  amount  occurs, depending 
on the duration of  fixation and other parameters.  
Results 
In nontumorous  pituitaries, the corticotrophs exhibited 
high levels of  labeling for P O M C  m R N A  (Fig. 1), which 
could not be correlated with the intensity of  A C T H  im- 
munostaining. The cort icotrophs extending into the pos- 
terior lobe expressed P O M C  m R N A  as well (Fig. 2). 
The signal intensity was comparable  or slightly lower 
than in the anterior lobe. The cells lining cavities repre- 
senting pars intermedia labeled intensely for P O M C  
m R N A .  
Crooke 's  cells, found in nontumorous  pituitaries ob- 
tained at surgery in association with functioning cortico- 
t roph adenomas,  contained moderate  to low levels o f  
P O M C  m R N A  (Fig. 3). A higher amount  of  labeling 
was found in Crooke 's  cells of  autopsy pituitaries. 
All functioning cort icotroph adenomas expressed 
P O M C  m R N A .  In well-differentiated, densely granulat- 
Discussion 
Anterior pituitary cort icotrophs are exposed to stimula- 
tory and inhibitory control, mediated by hypothalamic 
and other factors and by direct glucocorticoid feedback 
f rom the adrenal gland (Keller-Wood and Dal lman 
1984; Lundbad and Roberts 1988). Long-term treatment 
with corticotropin-releasing hormone  (CRH) or gluco- 
corticoids have a direct influence on the synthesis and 
release of  A C T H  and other POMC-derived peptides (re- 
viewed by Lundbad  and Roberts  1988). The molecular 
mechanisms of transcriptional activation and inhibition 
of  P O M C  gene are poorly understood. 
The POMC m R N A  can be demonstrated histologi- 
cally by ISH methods. The comparison of  ISH results 
with those of  dot blot quanti tat ion proved that ISH 
is an appropriate  technic for detecting m R N A s  both cy- 
tologically and quantitatively (Lewis et al. 1986). 
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Fig. 1. Anterior lobe of an autopsy pituitary gland exhibits groups of cells containing intense signal for POMC mRNA.  x 1400 
Fig. 2. Autopsy pituitary. Basophils extending into posterior lobe express POMC gene; in this field anterior lobe (asterisk) shows 
no POMC mRNA containing cells, x 1000 
Fig. 3. Nontumorous adenohypophysis of a patient with a functioning corticotroph adenoma contains Crooke's cells (arrows) with 
moderate to low POMC gene expression. ABC method for ACTH combined with ISH. x 1600 
Fig. 4. Functioning corticotroph adenoma associated with Cushing's disease exhibits intense labeling for POMC mRNA. x 1400 
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Fig. 5. Functioning corticotroph adenoma accompanied by Nelson's syndrome contains ACTH immunoreactive cells expressing POMC 
gene. x 1400 
Fig. 6. Silent subtype 1 corticotroph adenoma shows an intense hybridization signal in tumor cells, x 1400 
Fig. 7A, B. Silent subtype 2 adenoma presents very low hybridization for POMC mRNA (A). The preservation of mRNA in this specimen 
is proven by intense labeling with p(dT) probe that demonstrates poly-adenylated RNA (B). x 1600 
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Table 1. Immunocytochemical, ultrastructural and in situ hybridization results in functioning corticotroph adenomas 
Case no. Endocrine Immuno- Electron In situ 
manifestation reactivity microscopy hybridization 
1 Cushing's ACTH Typical + +, + + + 
disease features 
2 Cushing's ACTH Typical + +, + + + 
disease features 
3 Cushing's ACTH; Typical features; + +, + + + 
disease LH : focal signs of high 
secretory activity 
4 Cushing's ACTH; TSH, Typical features + + 
disease e-SU: few cells 
5 Cushing's ACTH; Typical features + + 
disease ct-SU : many cells 
6 Cushing's ACTH Sparsely granula- +, + + 
disease ted adenoma 
7 Cushing's ACTH Atypical adenoma + + 
disease 
8 Cushing's ACTH Two cell popula- + + 
disease tion: large 
Crooke's cells; 
small cells with 
signs of 
suppression 
9 Nelson's ACTH Typical features; + +, + + + 
syndrome no type 1 
filaments 
10 Nelson's ACTH Typical features; + 
syndrome few type 1 
filaments 
11 Nelson's ACTH Typical features: + +, + + + 
syndrome bundles of type 1 
filaments 
+, Weak labeling; + +, moderate labeling; + + +, intense labeling; ACTH, adrenocorticotrophic hormone; TSH, thyroid-stimulating 
hormone; LH, luteinizing hormone; a-SU, alfa subunit of glycoprotein hormones 
In nontumorous  pituitaries ISH analysis combined 
with immunocytochemistry revealed that  a high level of  
P O M C  m R N A  was present in most  A C T H  immunore-  
active cells, including those lining cavities of  the interme- 
diate lobe and those invading the posterior lobe. Variable 
amounts  of  P O M C  m R N A  were found in Crooke 's  cells, 
which are cort icotrophs suppressed due to glucocorti- 
coid excess. The glucocorticoid feedback inhibition of  
A C T H  release is rapid and progressive. The so-called 
delayed feedback occurs over hours to days and is ac- 
companied by unresponsiveness to C R F  and marked  de- 
creases in m R N A  (Birnberg et al. 1983). Depending on 
the duration, glucocorticoid exposure can induce total 
unresponsiveness of  the hypothalamic-pitui tary-adrenal  
axis to extreme stimuli, as observed in partients with 
Cushing's syndrome or long-term therapeutic exposure 
to glucocorticoids (Jones 1979; Keller-Wood and Dall- 
man  1984). In the human  pituitary, the Crooke 's  cells 
are readily identified due to massive, ring-like accumula- 
tion of  filaments. A few bundles of such filaments, mea- 
suring approximately 70 nm in width and representing 
cytokeratins disposed mainly around the nucleus, are 
unique morphologic markers  of  normal  and suppressed 
human  corticotrophs. In Crooke 's  cells, found in nontu- 
morous  adenohypophyses adjacent to a functioning cor- 
t icotroph adenoma,  low to modera te  amounts  of  hybrid- 
ization signal were detected, indicating that  P O M C  gene 
transcription is not completely inhibited in such cells. 
In the cort icotrophs with Crooke 's  change found in au- 
topsy pituitaries, the signal intensity was comparable  to 
that  of  normal  corticotrophs. Since we do not  have any 
data about  the duration of  glucocorticoid medication 
in these patients, the results cannot  be assessed. Crooke 's  
hyalinization is a reversible change that  gradually disap- 
pears after normalizat ion of  blood glucocorticoid levels. 
In most  functioning cort icotroph adenomas,  a high 
level of  P O M C  m R N A  was identified. This is not sur- 
prising since it is known that  in such tumors the feedback 
inhibition of  A C T H  by glucocorticoids is defective and 
that  the elevated plasma cortisol does not  decrease 
A C T H  secretion. A lower P O M C  gene expression was 
observed in some rarely occurring cort icotroph ad- 
enomas, such as the sparsely granulated variant,  an atyp- 
ical adenoma and an adenoma composed of  two cell 
populations,  a small cell component  with scanty RER,  
inconspicuous Golgi regions and small secretory gran- 
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Table 2. Immunocytochemical, ultrastructural and in situ hybridization results in silent adenomas 
Case no. Immuno- Electron In situ 
reactivity microscopy hybridization 
1 ACTH : diffuse Subtype 1 ; § +, + + + 
many Crooke's cells 
2 ACTH : diffuse Subtype 1 ; + + 
several Crooke's cells 
3 ACTH: diffuse Subtype 1 + + 
4 ACTH : diffuse Subtype 1 ; +, + + 
accumulation of lysosomes; 
extensive autophagy 
5 ACTH : groups Subtype 2 + 
of cells 
6 ACTH: isolated Subtype 2 0 
or small groups of cells 
7 ACTH : some groups of cells Subtype 2 + 
8 ACTH: diffuse Subtype 3 + 
9 ACTH: scattered Subtype 3 0 
cells; FSH, 
TSH : few cells 
10 GH, TSH, FSH, Subtype 3 
c~-SU : several cells; 
PRL: few cells 
11 TSH, FSH, ~-SU: Subtype 3 
several cells; GH, 
PRL: few cells 
0, Negative labeling; +, weak labeling; + +, moderate labeling; + + +, intense labeling; FSH, follicle stimulating hormone; PRL, 
prolactin 
ules and cells with Crooke 's  change. These results are 
in agreement with the clinical subtle form of  Cushing's 
disease observed in such patients (Horvath  and Kovacs 
1988). In adenomas associated with Cushing's disease 
and Nelson's syndrome, the intensity of  hybridization 
was not correlated with the amount  of  microfilaments 
present in adenoma cells in different cases. 
In silent subtype 1 cort icotroph adenomas,  the level 
of  P O M C  m R N A  was comparable  to that seen in func- 
tioning cort icotroph adenomas. The A C T H  immunore-  
activity and the intensity of  hybridization signal were 
evenly distributed among adenoma cells regardless of  
the percentage of  cells with Crooke 's  change. Our results 
are in agreement with those of  Lloyd et al. (1990) and 
suggest that, in this type of  silent adenoma,  the hormone 
synthesis is not inhibited at the transcription level. One 
can speculate that  in such tumors a defective mechanism 
of  P O M C  processing or peptides release exists. Abnor-  
mal  processing of  precursor peptide caused by point mu- 
tation(s) in P O M C  m R N A  is one possibility. However,  
in one silent cort icotroph adenoma,  Nagaya  et al. (1990) 
could not identify any abnormali ty  in P O M C  size and 
coding sequence. In some cort icotroph adenomas,  gel 
chromatography  analysis demonstrated the predomi- 
nant  secretion of  a high molecular weight A C T H  with 
a low biologic activity. In such tumors,  the hormone 
release was not disturbed and the patients presented with 
or without Cushing's disease (Fuller et al. 1984; Reincke 
et al. 1987). 
In silent subtype 2 and 3 adenomas,  the P O M C  gene 
transcription was consistently low, indicating that  a re- 
duced rate of  hormone  synthesis can be responsible for 
the lack of  endocrine symptoms. Morphologically, silent 
subtype 2 adenomas have some ultrastructural features 
of  corticotrophs, such as the shape of  cell and secretory 
granules, but they lack type 1 microfilaments; A C T H  
immunoreactivi ty is present in a variable number  of  
cells. Silent subtype 3 adenomas initially were included 
in the group of  cort icotroph adenomas due to their im- 
munoreactivi ty for A C T H  and other POMC-derived 
peptides (Horvath  et al. 1980). As more  cases were inves- 
tigated, it became evident that some adenomas con- 
tained no ACTH,  and focal immunoposit ivi ty for other 
hormones was a frequent finding. Since silent subtype 3 
adenoma is a well-defined entity by electron microscopy 
with no features reminiscent of  corticotrophs, it is at 
present considered a separate group and its cellular ori- 
gin remains obscure (Horvath  et al. 1988). In situ hybrid- 
ization studies indicate a low amount  of  P O M C  m R N A  
or none at all in silent subtype 3 adenomas.  PRL gene 
expression was found in one case of  silent subtype 3 
tumor  by Lloyd et al. (1990). The application of  probes 
for glycoprotein hormones may contribute to prove the 
suggested potential of  multidirectional differentiation of 
these tumors. 
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